Company profile: Cellular Biomedicine Group
1.1 - Company Overview
Company description
- Provider of clinical-stage biopharmaceutical development focused on immunotherapies for cancers and stem cell therapies for degenerative diseases, utilizing proprietary cell therapy technologies built on thirty years of research and human treatment experience.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellular Biomedicine Group
CytoSolv
HQ: United States
Website
- Description: Provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoSolv company profile →
CytoSen
HQ: United States
Website
- Description: Provider of natural killer (NK) cell therapeutics focused on advancing effective, expedient, and accessible NK cell therapy to fight cancer for patients and providers across a wide range of points of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoSen company profile →
Tissue Genesis
HQ: United States
Website
- Description: Provider of advanced tissue engineering and cell therapy solutions, offering the Icellator2 automated device to extract adult stem cells from adipose tissue for high-yield SVF cells in about an hour, and the sterile, single-use Cell Icellation Kit for efficient SVF isolation with the Icellator2.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tissue Genesis company profile →
Orthofix
HQ: United States
Website
- Description: Provider of medical devices and digital solutions for spine procedures (alignment, disc height improvement, nerve decompression, instability correction); biologics including viable-cell allografts, structural allografts, synthetic bone grafts, and amniotic membranes; PEMF bone growth therapy for spinal fusion and nonunion fractures; and the Fitbone motorized intramedullary nail for femur/tibia transport or lengthening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orthofix company profile →
HemoGenyx Pharmaceuticals
HQ: United Kingdom
Website
- Description: Provider of cell-based and antibody immunotherapies for blood diseases. Offerings include HEMO-CAR-T, a modified T-cell therapy for Acute Myeloid Leukemia (AML); CDX, a bispecific monoclonal antibody for relapsed/refractory AML and conditioning for bone marrow transplantation; and CBR, an immunotherapy platform to prevent and combat viral infections and certain cancers, with proof of concept for SARS-COV-2.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HemoGenyx Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellular Biomedicine Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellular Biomedicine Group
2.2 - Growth funds investing in similar companies to Cellular Biomedicine Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellular Biomedicine Group
4.2 - Public trading comparable groups for Cellular Biomedicine Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →